An anesthesiologist administers vecuronium (non-depolarizing NMJ blocker) and notes no pupillary changes, no change in heart rate, and no change in bowel sounds. Why does vecuronium not affect autonomic ganglia or the heart?

• A Vecuronium selectively blocks nicotinic NMJ receptors (N2/Nm subtype) while autonomic ganglia and cardiac parasympathetic junctions use different nicotinic receptor subtypes (N1/Nn) with different pharmacology ✓
• B Vecuronium cannot cross the autonomic ganglia membrane due to its quaternary ammonium structure
• C Autonomic ganglia use muscarinic receptors which are not affected by vecuronium
• D The dose of vecuronium used for NMJ blockade is below the threshold required for autonomic effects at ganglia

Explanation

Nicotinic receptors at the neuromuscular junction (Nm, also called N2) have a different subunit composition (α1, β1, δ, ε) compared to autonomic ganglionic nicotinic receptors (Nn, N1; composed of α3, β4 subunits). Non-depolarizing muscle relaxants like vecuronium are specifically designed to block NMJ nicotinic receptors with high selectivity, causing minimal ganglionic blockade at clinical doses. Option B (membrane impermeability) is not the primary reason; option C is incorrect as ganglionic transmission uses nicotinic, not muscarinic receptors; option D is an oversimplification as the selectivity is pharmacological, not purely dose-dependent.

Reference: Guyton & Hall, Textbook of Medical Physiology, 14th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.